| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
357,741,000 |
| Market
Cap: |
133.31(B) |
| Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
| 52
Week Range: |
$258.49 - $400.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1071 |
| Guru Rank Value : -4.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
261,565 |
310,203 |
401,165 |
779,048 |
| Total Sell Value |
$100,839,669 |
$114,309,929 |
$143,376,644 |
$237,969,083 |
| Total People Sold |
9 |
9 |
12 |
12 |
| Total Sell Transactions |
24 |
29 |
41 |
68 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Miller Brian Edward |
EVP & Chief Digital Officer |
• – – |
2024-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,650 |
11,432 |
|
- |
|
| Charlton Henry L |
SVP & Chief Commercial and Mkt |
• – – |
2024-02-26 |
4 |
D |
$389.77 |
$149,672 |
D/D |
(384) |
22,265 |
|
- |
|
| Charlton Henry L |
SVP & Chief Commercial and Mkt |
• – – |
2024-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,284 |
22,649 |
|
- |
|
| Guthart Gary S |
CEO |
• • – |
2024-02-26 |
4 |
D |
$389.77 |
$598,687 |
D/D |
(1,536) |
12,218 |
|
- |
|
| Guthart Gary S |
CEO |
• • – |
2024-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,030 |
13,754 |
|
- |
|
| Brosius Mark |
SVP & Chief Mfg and Supply Cha |
• – – |
2024-02-16 |
4 |
AS |
$378.29 |
$12,105 |
D/D |
(32) |
709 |
|
- |
|
| Brosius Mark |
SVP & Chief Mfg and Supply Cha |
• – – |
2024-02-15 |
4 |
AS |
$382.03 |
$11,461 |
D/D |
(30) |
741 |
|
- |
|
| Leonard Keith R |
Director |
– • – |
2024-02-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,547 |
1,037 |
|
- |
|
| Brosius Mark |
SVP & Chief Mfg and Supply Cha |
• – – |
2024-02-14 |
4 |
AS |
$380.09 |
$11,403 |
D/D |
(30) |
771 |
|
- |
|
| Brosius Mark |
SVP & Chief Mfg and Supply Cha |
• – – |
2024-02-13 |
4 |
AS |
$375.51 |
$11,265 |
D/D |
(30) |
801 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2024-02-12 |
4 |
AS |
$386.09 |
$185,709 |
D/D |
(481) |
298 |
|
- |
|
| Brosius Mark |
SVP & Chief Mfg and Supply Cha |
• – – |
2024-02-12 |
4 |
AS |
$386.09 |
$11,583 |
D/D |
(30) |
831 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2024-02-10 |
4 |
D |
$388.22 |
$138,595 |
D/D |
(357) |
779 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
838 |
1,136 |
|
- |
|
| Mohr Marshall |
Executive VP Global Business S |
• – – |
2024-02-10 |
4 |
D |
$388.22 |
$421,219 |
D/D |
(1,085) |
26,034 |
|
- |
|
| Mohr Marshall |
Executive VP Global Business S |
• – – |
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,873 |
27,119 |
|
- |
|
| Samath Jamie |
Chief Financial Officer |
• – – |
2024-02-10 |
4 |
D |
$388.22 |
$155,676 |
D/D |
(401) |
6,913 |
|
- |
|
| Samath Jamie |
Chief Financial Officer |
• – – |
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,078 |
7,314 |
|
- |
|
| Widman Fredrik |
VP Corporate Controller |
• – – |
2024-02-10 |
4 |
D |
$388.22 |
$86,185 |
D/D |
(222) |
2,689 |
|
- |
|
| Widman Fredrik |
VP Corporate Controller |
• – – |
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
568 |
2,911 |
|
- |
|
| Loeb Gary |
General Counsel |
• – – |
2024-02-10 |
4 |
D |
$388.22 |
$50,080 |
D/D |
(129) |
1,895 |
|
- |
|
| Loeb Gary |
General Counsel |
• – – |
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
315 |
2,024 |
|
- |
|
| Rosa David J. |
President |
• • – |
2024-02-10 |
4 |
D |
$388.22 |
$283,012 |
D/D |
(729) |
215,097 |
|
- |
|
| Rosa David J. |
President |
• • – |
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,437 |
215,826 |
|
- |
|
| Desantis Robert |
EVP & Chief Strategy & Corp Op |
• – – |
2024-02-10 |
4 |
D |
$388.22 |
$122,678 |
D/D |
(316) |
8,010 |
|
- |
|
1324 Records found
|
|
Page 3 of 53 |
|
|
5.92 (1.56%) 
